Apyx medical corp (BVX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Net loss

-

-

-

-3,950

-

-

-

-

-

-

-

Cash flows from operating activities
Net income (loss)

-19,706

62,719

-5,062

-

-5,370

-17,282

-4,339

617

-

-1,535

596

Net income (loss)

-

-

-

-

-

-

-

-

109

-

-

Adjustments to reconcile net loss to net cash used in operating activities:
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax

0

68,404

0

0

-

-

-

-

-

-

-

Depreciation and amortization

754

669

696

734

812

876

827

742

753

734

777

Provision for inventory obsolescence

132

0

0

-

-

-

-

-

-

-

-

Provision for product warranties

321

0

0

-

-

-

-

-

-

-

-

Amortization of intangible assets

-

-

-

-

-

-

-

115

-

-

-

Amortization of intangible assets

-

-

-

-

-

-

-

-

172

273

273

Provision for inventory obsolescence

-

-

-

-

157

733

12

-93

37

-8

27

Gain on disposal of property and equipment, net

-89

0

-5

-21

-21

-14

-16

41

0

-

-

Loss on disposal of property and equipment, net

-

-

-

-

-

-

-

-

-

-326

1

Loss on impairment Bovie Canada

-

-

-

-

-

-

-

-

-

54

0

Loss on impairment of intangible assets

-

-

-

-

-

-

-

-

-

1,286

0

Stock based compensation

3,581

2,224

871

809

575

388

506

161

132

163

136

Change in fair value of derivative liabilities

0

-20

-183

-64

-

-

-

-

-

-

-

Unrealized gain on short term investments

164

247

0

-

-

-

-

-

-

-

-

Unrealized gain on short term investments

-

-

-

0

-

-

-

-

-

-

-

Change in fair value of derivative liabilities

-

-

-

-

1,799

-7,285

-

-

-

-

-

Provision (benefit) for allowance for doubtful accounts

-163

224

179

84

96

-

-

-

-

-

-7

Benefit of deferred taxes

0

368

196

-25

-

-

-

-

-

-

-

Provision for allowance for doubtful accounts

-

-

-

-

-

-93

-

-

-

-

-

Benefit of deferred taxes

-

-

-

-

-25

3,975

-

-

-

-

-

Non cash other (income) loss - warrants

-

-

-

-

-

-

-884

20

-

-

-

Non cash other income - warrants

-

-

-

-

-

-

-

-

227

513

0

Non cash finance costs allocated to warrants

-

-

-

-

-

-

-

-

0

-

-

Non cash other income - Lican

-

-

-

-

-

-

-

-

61

0

0

Non cash legal settlement

-

-

-

-

-

-

-

-

954

0

0

Benefit (provision) for deferred taxes

-

-

-

-

-

-

-1,613

210

-76

-934

60

Changes in operating assets and liabilities:
Gain on cancellation of agreement

-

-

-

-

-

-

-

-

-

-

0

Trade receivables

3,970

447

303

1,894

1,029

-90

-884

658

126

-451

-440

Prepaid expenses and other assets

406

2,851

30

-103

-286

259

-406

241

-257

47

-150

Inventories

2,367

-1,185

368

201

102

-1,955

884

-287

719

822

1,462

Deposits and other assets

-

-

-

341

228

952

-234

-227

-

-

-

Deposits

-

-

-

-

-

-

-

-

-111

-281

-305

Accounts payable

1,054

-224

-23

392

-189

494

257

-284

134

362

-728

Accrued severance and related

-

-

-

0

0

-

-

-

-

-

-

Litigation settlement liability

-

-

-

-

-

-

-

-

731

0

0

Accrued and other liabilities

2,370

-15,341

710

763

553

455

742

-403

-30

-56

-3

Accrued payroll

-

-

-

-

-

-

-

-

-12

23

17

Accrued vacation

-

-

-

-

-

-

-

-

-20

-2

-67

Net cash used in operating activities

-18,475

-20,881

-3,704

-2,837

-5,786

-417

-2,536

165

1,897

-526

-97

Cash flows from investing activities
Purchases of property and equipment

1,301

363

624

286

421

630

588

753

542

201

2,465

Proceeds from the disposition of Core business

0

91,095

0

0

-

-

-

-

-

-

-

Purchases of marketable securities

18,884

87,189

0

0

-

-

-

-

-

-

-

Proceeds from maturities of marketable securities

80,726

25,758

0

0

-

-

-

-

-

-

-

Acquisition of Bovie Bulgaria, net of cash acquired

-

-

-

-

500

0

0

-

-

-

-

Proceeds from sale of property and equipment

-

-

-

-

-

-

-

-

-

633

1

Increase in purchased technology

-

-

-

-

-

-

-

-

-

-

0

Net cash (used in) provided by investing activities

60,541

29,301

-624

-286

-921

-630

-588

-753

-542

432

-2,464

Cash flows from financing activities
Proceeds from stock option exercises

207

202

0

124

1,427

259

-

-

-

-

-

Repayment of finance lease liabilities

60

0

0

-

-

-

-

-

-

-

-

Proceeds from stock options/warrants exercised

-

-

-

-

-

-

7,048

0

-

-

-

Change in restricted cash

-

-

-

-

-60

899

0

0

-

-

-

Repayment of mortgage note payable

-

-

-

-240

-239

3,173

-

-

-

-

-

Proceeds from long-term debt

-

-

-

-

-

-

-

-

3,549

0

0

Repayment of mortgage note payable

0

2,694

239

-

-

-

0

0

3,740

135

175

Proceeds from convertible preferred stock and warrants

-

-

-

-

-

-

-

-

0

-

-

Proceeds from mortgage note payable to bank (net of amounts in escrow)

-

-

-

-

-

-

-

-

-

36

1,249

Proceeds from private placement (net of costs of $233)

-

-

-

-

-

-

-

-

-

2,767

0

Net change in line of credit

-

-

-

-

-

-

-

-

-

1,000

-1,000

Repayments of capital lease payable

-

-

-

-

-

-

-

-

111

0

0

Proceeds from issuance of common shares, net

-

-

-

5,830

11,531

0

0

-

-

9

79

Repayment of industrial revenue bonds

-

-

-

-

-

3,257

162

130

-

-

-

Repurchase of warrants

-

-

-

-

-

420

0

0

-

-

-

Net cash provided by financing activities

147

-2,492

-239

5,714

12,779

-1,144

6,886

-130

-302

1,677

2,153

Effect of exchange rates on cash

3

0

0

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash

42,216

5,928

-4,567

-

-

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash

-

-

-

2,591

-

-

-

-

-

-

-

Effect of exchange rate changes on cash and cash equivalents

-

-

-

-

-

-

-

-

-

89

-1

Net change in cash and cash equivalents

-

-

-

-

6,072

-2,191

3,762

-718

1,053

1,672

-409

Cash paid for:
Interest

8

104

136

158

-

-

-

-

-

-

-

Income taxes

325

13,283

32

27

-

-

0

0

0

0

-245

Non cash operating activities:
Transfer of other assets to fixed assets

42

0

0

-

-

-

-

-

-

-

-

Transfer of inventory to fixed assets

277

0

0

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

158

151

195

232

-237

-223

-128

Non cash financing activities:
Cashless exercise of stock options/warrants

612

3,237

557

-

-

-

-

-

-

-

-

Note payable for acquisitions

-

-

-

-

140

0

0

-

-

-

-

Cashless exercise of stock options/warrants

-

-

-

698

272

-

-

-

-

-

-

Equipment financed with loan

-

-

-

-

-

-

-

-

-

-111

-111